about
The Emerging Role of MicroRNA-155 in Cardiovascular DiseasesMicroRNA Expression Signature in Human Calcific Aortic Valve Disease.Deregulated Cardiac Specific MicroRNAs in Postnatal Heart GrowthTherapeutic potential of targeting microRNAs to regulate cardiac fibrosis: miR-433 a new fibrotic player.miR-17-3p Contributes to Exercise-Induced Cardiac Growth and Protects against Myocardial Ischemia-Reperfusion Injury.Bioinformatics Analysis Reveals MicroRNAs Regulating Biological Pathways in Exercise-Induced Cardiac Physiological Hypertrophy.Targeting EZH1 and EZH2 contributes to the suppression of fibrosis-associated genes by miR-214-3p in cardiac myofibroblasts.The correlation between pulmonary fibrosis and methylation of peripheral Smad3 in cases of pigeon breeder's lung in a Chinese Uygur population.The Role and Molecular Mechanism of Non-Coding RNAs in Pathological Cardiac Remodeling.Modulating microRNAs as Novel Therapeutic Targets in Cardiac Fibrosis.miR-224 Controls Human Colorectal Cancer Cell Line HCT116 Proliferation by Targeting Smad4.Micro-RNAs as promising biomarkers in cardiac diseases.Cardiac fibrosis and miR-433.miR-31a-5p promotes postnatal cardiomyocyte proliferation by targeting RhoBTB1.MicroRNA-130a, a Potential Antifibrotic Target in Cardiac Fibrosis.MicroRNA-327 regulates cardiac hypertrophy and fibrosis induced by pressure overload.Therapeutic potential of microRNAs for the treatment of renal fibrosis and CKD.MicroRNA-30c suppresses the pro-fibrogenic effects of cardiac fibroblasts induced by TGF-β1 and prevents atrial fibrosis by targeting TGFβRII.miR-133: A Suppressor of Cardiac Remodeling?
P2860
Q28072949-71BB61FF-3F06-44B1-BF72-14F691459D97Q33604025-6BABE9A3-F553-4D55-9460-14FFF6318EB0Q37571543-1F56CC7D-3571-4DAF-ABAB-7768F133EA1AQ37583782-08A51A5D-B7BD-4843-857F-6D2254FF888AQ37668558-38D7F1C9-7383-453F-811E-AA4BB7533CECQ37670773-8DF74C40-DDF0-409E-A4F9-5FE3DFADE6D3Q37694630-B75A738E-8891-4BF8-8F23-A37DD101178DQ38754119-3B1E9138-9FBA-4CCE-9E2A-CC677404D822Q39175956-101DA9F5-F6B1-4C55-9602-57E885FC4BE2Q40980413-9E1A9021-C4C9-4031-AB6C-46741200483BQ41035735-2A01F8D0-9324-474D-BFFF-9F9D1119B7F8Q41908255-7412BAB3-BA7A-47FE-91CA-10C98EEAE909Q42330854-4E497067-30A1-47B4-82FE-9A02A86E6E73Q44222557-EA2BE24F-4970-4430-A1C5-FEA295C9C3BEQ47136571-14F66308-65AA-4ABB-9F59-0CC359D14D99Q49379816-17ABE482-A8D1-4F64-B954-4D4251C08C59Q50063239-3D6619F9-D87A-4D47-8D2F-974E800FD111Q52658507-5B828442-3C31-43F3-B49C-C703A35644F5Q58769694-7BAC256C-22EE-4369-9366-871A48B139E6
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Crucial Role of miR-433 in Regulating Cardiac Fibrosis
@en
Crucial Role of miR-433 in Regulating Cardiac Fibrosis.
@nl
type
label
Crucial Role of miR-433 in Regulating Cardiac Fibrosis
@en
Crucial Role of miR-433 in Regulating Cardiac Fibrosis.
@nl
prefLabel
Crucial Role of miR-433 in Regulating Cardiac Fibrosis
@en
Crucial Role of miR-433 in Regulating Cardiac Fibrosis.
@nl
P2093
P2860
P356
P1433
P1476
Crucial Role of miR-433 in Regulating Cardiac Fibrosis
@en
P2093
Dragos Cretoiu
Haifeng Zhang
Jiahong Xu
Jiuchang Zhong
Junjie Xiao
Lichan Tao
P2860
P304
P356
10.7150/THNO.15007
P577
2016-09-10T00:00:00Z